Viewing Study NCT03463733


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2025-12-26 @ 1:24 AM
Study NCT ID: NCT03463733
Status: UNKNOWN
Last Update Posted: 2020-10-08
First Post: 2018-03-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
Sponsor: M.E. van Linde
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module